FDA Accepts The Medicines Co.'s NDA

FDA Accepts The Medicines Co.'s NDA

The Medicines Company (MDCO) recently announced the acceptance of its new drug application (:NDA) for its antiplatelet candidate, Cangrelor, by the US Food and Drug Administration (:FDA). The Medicines Co. is looking to get Cangrelor approved for use 

7
Like
Save

Comments

Write a comment

*